These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 10619859)
1. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859 [TBL] [Abstract][Full Text] [Related]
2. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698 [TBL] [Abstract][Full Text] [Related]
3. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival. Hamrah P; Yamagami S; Liu Y; Zhang Q; Vora SS; Lu B; Gerard CJ; Dana MR Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1228-36. PubMed ID: 17325167 [TBL] [Abstract][Full Text] [Related]
4. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046 [TBL] [Abstract][Full Text] [Related]
5. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
6. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection. Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343 [TBL] [Abstract][Full Text] [Related]
14. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival. Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748 [TBL] [Abstract][Full Text] [Related]
15. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y; Tang XD; Zhou PJ Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [TBL] [Abstract][Full Text] [Related]
16. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A. Li J; Xia J; Zhang K; Xu L J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762 [TBL] [Abstract][Full Text] [Related]
18. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK; Shelby J; Eichwald EJ Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070 [TBL] [Abstract][Full Text] [Related]
19. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection. Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334 [TBL] [Abstract][Full Text] [Related]
20. Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells. Liu Z; Hou J; Chen J; Tsumura H; Ito M; Ito Y; Hu X; Li XK Transplantation; 2012 Jun; 93(11):1116-24. PubMed ID: 22588539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]